Fish oils in chronic kidney disease

Active, not recruiting

• Conditions: Kidney Disease; Renal and Urogenital - Kidney disease

• Registration Number: ACTRN12607000455460
• Lead Sponsor: Queensland University of Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-09-10
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Adult chronic kidney disease patients aged > 18 years who have been receiving hemodialysis for > 3 months.

Exclusion Criteria

Taking a fish oil supplement providing > 500 mg/day, aged < 18 years, on hemodialysis < 3 months, presence of emotional, cognitive or language limitations impairing their ability to provide informed consent or follow study instructions (where a carer or translator is not available).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Appetite, measured by: 1) Rating appetite on a Likert scale 2) Rating appetite on a visual analog scale, plus 3) blood markers (leptin, ghrelin, peptide YY, glucopeptide-1).[Pre-baseline, baseline, week4, week 8 and week 12.]

Secondary Outcome Measures

Name	Time	Method
Inflammation, measured by the following markers: 1) Interleukin 6, 2) C-reactive protein 3) Adhesion molecules 4) White cell count.[Prebaseline, baseline and week 12.];Quality of Life, measured by the Kidney Disease Quality of Life questionnaire.[Baseline and week 12];Dietary Intake, measured by 3-day food record kept by the participants which will later be reviewed by the trial's research staff and analysed using Foodworks ver 3.0 (Xyris software).[Prebaseline, baseline and week 12]